Report : Asia Pacific Starch Softgel Capsules Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Application (Pharmaceutical, Health Supplements, Others); Distribution Channel (Supermarket and Hypermarket, Pharmacy and Drugstore, Online Provider); and Country
According to The Insight Partners market research study of “Asia Pacific Starch Softgel Capsules Market Forecast to 2027 - Covid-19 Impact and Region Analysis by Application and Distribution Channel,” Asia Pacific Starch Softgel Capsules Market is projected to reach US$ 122.54 million in 2027 from US$ 82.55 million in 2019. The market is estimated to grow at CAGR of 5.2% from 2020 to 2027. The report highlights trends prevailing in the Asia Pacific starch softgel capsules market and the factors driving market along with those that act as hindrances.
The Asia Pacific Starch Softgel Capsules Market, based on distribution channel, is further segmented into pharmacy and drugstore, supermarket and hypermarket and online provider. The online provider segment is expected to grow at the fastest rate during the forecast period. Owing to factors like millennials preference for online purchasing, discounts on online shopping and customer reviews of the products, drives the growth of the online provider segment during the forecast period.
Asia Pacific starch softgel capsules market is expected to grow owing to factors such as advantages of Softgel capsules and rise in preference for vegetarian capsules in Asian countries is expected to boost the market growth over the years. However, difficulties in optimizing cellulose/starch for API delivery is likely to have a negative impact on the growth of the market in the coming years.
Leading companies operating in the Asia Pacific starch softgel capsules market are Hunan Er-Kang Pharmaceutical Co., Ltd, Softcaps,Fuji Capsule Co., Ltd.,Aenova Holding GmbH,Sirio Pharma Co., Ltd., among others.
The report segments Asia Pacific Starch Softgel Capsules Market as follows:
By Distribution Channel